Cancer Res Treat.  2020 Apr;52(2):419-425. 10.4143/crt.2018.648.

Changes of End of Life Practices for Cancer Patients and TheirAssociation with Hospice Palliative Care Referral over 2009-2014:A Single Institution Study

Affiliations
  • 1Department of Hospice Palliative Service, National Cancer Center, Goyang, Korea
  • 2Information Technology Team, National Cancer Center, Goyang, Korea
  • 3Department of Oncology, University of Ulsan College of Medicine, Seoul, Korea

Abstract

Purpose
In Korea, hospice palliative care (HPC) provision for cancer patients has increased recently. However, whether end of life (EoL) care practices have improved along with the development of HPC is unclear. We intended to investigate the changes in EoL care practices and their association with HPC referral.
Materials and Methods
Retrospective medical record review of adult cancer patients who died at National Cancer Center Korea from 1 January 2009 to 31 December 2014 was performed. Changes of EoL practices including chemotherapy within 2 weeks from death, death in intensive care unit (ICU), documentation of “do not resuscitate (DNR)” within 7 days from death and referral to HPC from 2009 to 2014 were analyzed as well as the association between referral to HPC and other practices.
Results
A total of 2,377 cases were included in the analysis. Between 2009 and 2014, referral to HPC increased and DNR documentation within 7 days from death decreased significantly. Cases for chemotherapy within 2 weeks from death and death in ICU didn’t change over the study period. Patients referred to HPC were less likely to receive chemotherapy within 2 weeks from death, die in ICU and document DNR within 7 days from death.
Conclusion
During the study period, EoL practices among cancer patients partly changed toward less aggressive in our institution. HPC referral was associated with less aggressive cancer care at the EoL. Policies to promote EoL discussion are necessary to improve the EoL practices of cancer patients.

Keyword

Neoplasms; Hospice and palliative care; Terminal care; Chemotherapy; Aggressiveness

Figure

  • Fig. 1. Trends of end of life care practices from 2009 to 2014. DNR, Do Not Resuscitate; ICU, intensive care unit.


Cited by  3 articles

Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
Cancer Res Treat. 2020;52(3):917-924.    doi: 10.4143/crt.2019.740.

Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study
Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
Cancer Res Treat. 2021;53(2):584-592.    doi: 10.4143/crt.2020.735.

A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making?
So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh
Cancer Res Treat. 2021;53(2):593-600.    doi: 10.4143/crt.2020.803.


Reference

References

1. Economist Intelligence Unit. The 2015 Quality of Death Index: ranking palliative care across the world. Singapore: Lien Foundation;2015.
2. Woitha K, Carrasco JM, Clark D, Lynch T, Garralda E, MartinMoreno JM, et al. Policy on palliative care in the WHO European region: an overview of progress since the Council of Europe's (2003) recommendation 24. Eur J Public Health. 2016; 26:230–5.
Article
3. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008; 26:3860–6.
Article
4. Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end of life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011; 29:1587–91.
5. Jang RW, Krzyzanowska MK, Zimmermann C, Taback N, Alibhai SM. Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. J Natl Cancer Inst. 2015; 107:dju424.
Article
6. Taberner Bonastre P, Taberner Bonastre MT, Soler Company E, Perez-Serrano Lainosa MD. Chemotherapy near the end of life; assessment of the clinical practise in onco-hematological in adult patients. Farm Hosp. 2016; 40:14–24.
7. Chang TS, Su YC, Lee CC. Determinants for aggressive end-of-life care for oral cancer patients: a population-based study in an Asian country. Medicine (Baltimore). 2015; 94:e460.
8. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363:733–42.
Article
9. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300:1665–73.
Article
10. Balaban RB. A physician's guide to talking about end-of-life care. J Gen Intern Med. 2000; 15:195–200.
Article
11. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012; 30:880–7.
Article
12. Teno JM, Shu JE, Casarett D, Spence C, Rhodes R, Connor S. Timing of referral to hospice and quality of care: length of stay and bereaved family members' perceptions of the timing of hospice referral. J Pain Symptom Manage. 2007; 34:120–5.
Article
13. Morita T, Akechi T, Ikenaga M, Kizawa Y, Kohara H, Mukaiyama T, et al. Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005; 23:2637–44.
Article
14. Hospice and Palliative Care. Hospice and palliative care in Korea: facts and figures 2017. Goyang: Hospice and Palliative Care;2019.
15. Hospice and Palliative Care [Internet]. Goyang: Hospice and Palliative Care;2019. [cited 2019 Jul 3]. Available from: http://hospice.cancer.go.kr.
16. Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY, et al. Chemotherapy use and associated factors among cancer patients near the end of life. Oncology. 2007; 72:164–71.
Article
17. Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, et al. CPR or DNR?: end-of-life decision in Korean cancer patients: a single center's experience. Support Care Cancer. 2006; 14:103–8.
Article
18. Kim DY, Lee KE, Nam EM, Lee HR, Lee KW, Kim JH, et al. Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med. 2007; 10:1153–8.
Article
19. Baek YJ, Shin DW, Choi JY, Kang J, Mo HN, Kim YH, et al. Late referral to palliative care services in Korea. J Pain Symptom Manage. 2011; 41:692–9.
20. Choi Y, Keam B, Kim TM, Lee SH, Kim DW, Heo DS. Cancer treatment near the end-of-life becomes more aggressive: changes in trend during 10 years at a single institute. Cancer Res Treat. 2015; 47:555–63.
Article
21. Yoo SH, Keam B, Kim M, Kim TM, Kim DW, Heo DS. The effect of hospice consultation on aggressive treatment of lung cancer. Cancer Res Treat. 2018; 50:720–8.
Article
22. Park SJ, Nam EJ, Chang YJ, Lee YJ, Jho HJ. Factors related with utilizing hospice palliative care unit among terminal cancer patients in Korea between 2010 and 2014: a single institution study. J Korean Med Sci. 2018; 33:e263.
Article
23. Amano K, Morita T, Tatara R, Katayama H, Uno T, Takagi I. Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life. J Palliat Med. 2015; 18:270–3.
Article
24. Maltoni M, Scarpi E, Dall'Agata M, Schiavon S, Biasini C, Codeca C, et al. Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer. 2016; 69:110–8.
Article
25. Lee HS, Chun KH, Moon D, Yeon HK, Lee S, Lee S. Trends in receiving chemotherapy for advanced cancer patients at the end of life. BMC Palliat Care. 2015; 14:4.
Article
26. Lee SW, Jho HJ, Baek JY, Shim EK, Kim HM, Ku JY, et al. Outpatient palliative care and aggressiveness of end-of-life care in patients with metastatic colorectal cancer. Am J Hosp Palliat Care. 2018; 35:166–72.
Article
27. Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014; 120:1572–8.
Article
28. Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care?: a systematic review and meta-analysis of published data. Palliat Med. 2011; 25:630–41.
Article
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr